½ÃÀ庸°í¼­
»óǰÄÚµå
1822546

¼¼°èÀÇ ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, ¾÷°è µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

Ophthalmic Lasers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Global Market Insights, Inc.°¡ ¹ßÇàÇÑ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀåÀº 2024³â¿¡ 18¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, CAGR 5.9%·Î È®´ëµÇ¾î 2025³â 19¾ï ´Þ·¯¿¡¼­ 2034³â±îÁö 31¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ½Ã·Â Àå¾ÖÀÇ ÀÌȯÀ² Áõ°¡, ³ëÈ­, ¾È°ú ¼ö¼ú¿ë ·¹ÀÌÀú ½Ã½ºÅÛÀÇ ±â¼ú Áøº¸¿¡ ÀÇÇØ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

¾È°ú¿ë ·¹ÀÌÀú ¸¶ÄÏ-IMG1

¾È°ú¿ë ·¹ÀÌÀú´Â ³ì³»Àå, ´ç´¢º´¼º ¸Á¸·Áõ, ¿¬·É Ȳ¹Ýº¯¼º(AMD), ±¼Àý ÀÌ»ó°ú °°Àº ÁúȯÀÇ Ä¡·á¿¡ ÇʼöÀûÀÎ °ÍÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¾È°ú¿ë ·¹ÀÌÀú´Â Á¤È®Çϰí È¿°úÀûÀÎ ¼ö¼úÀ» Á¦°øÇÏ´Â ³·Àº ħ½À ÀåºñÀ̱⠶§¹®¿¡ ÇâÈÄ ¸î ³â µ¿¾È º¸±ÞÀÌ ÁøÇàµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ±Ý¾× 18¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 31¾ï ´Þ·¯
CAGR 5.9%

ÁÖ¿ä ÃËÁø¿äÀÎ

1. ¾ÈÁúȯ Áõ°¡ : ¹é³»Àå, ´ç´¢º´¼º ¸Á¸·Áõ, ³ì³»Àå Áõ°¡·Î ·¹ÀÌÀú ±â¹Ý Ä¡·á ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

2. ±¼Àý ±³Á¤ ¼ö¼ú Áõ°¡ : ÀþÀº ¼¼´ëÀÇ ¶ó½Ä°ú SMILE ¼ö¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ÆèÅäÃÊ ·¹ÀÌÀú¿Í ¿¢½Ã¸Ó ·¹ÀÌÀúÀÇ »ç¿ëÀ» ÃËÁøÇÕ´Ï´Ù.

3. ·¹ÀÌÀúÀÇ Á¤È®¼º°ú ¾ÈÀü¼º Çâ»ó : »õ·Î¿î ¾È°ú¿ë ·¹ÀÌÀú´Â º¸´Ù Áøº¸µÈ ÅëÁ¦, ´õ ÀûÀº ¿­ ¼Õ»ó, ´õ ³ªÀº ¼ö¼ú ÈÄ °á°ú¸¦ Á¦°øÇϱâ À§ÇØ ¾È°ú ÀÇ»çµé »çÀÌ¿¡¼­ ÁöÁö¸¦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù.

4. Àα¸ °í·ÉÈ­ : ³ëÈ­¿Í °ü·ÃµÈ ¾ÈÁúȯÀº ƯÈ÷ °í¼Òµæ ±¹°¡¿Í Áß¼Òµæ ±¹°¡¿¡¼­ ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷

  • Alcon, Johnson & Johnson, ZEISS, LUMENIS, NIDEK µîÀÌ ÁÖ¿ä ±â¾÷À¸·Î ½ÃÀå ÀüüÀÇ 59.3%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
  • AlconÀº 2024³â ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀå¿¡¼­ 18.2%ÀÇ Á¡À¯À²À» ȹµæÇß½À´Ï´Ù.

ÁÖ¿ä °úÁ¦

  • ÀåºñÀÇ ³ôÀº ºñ¿ë : ¾È°ú¿ë ·¹ÀÌÀú´Â °í°¡À̱⠶§¹®¿¡ Àú¼Òµæ ÀÇ·á½Ã¼³·ÎÀÇ º¸±ÞÀÌ ÀúÇØµË´Ï´Ù.
  • ¾ö°ÝÇÑ ±ÔÁ¦ ´ç±¹ ½ÂÀÎ : ´Ù¾çÇÑ ½ÃÀå¿¡¼­ À§±â ½ÂÀÎ Áö¿¬À¸·Î ÀÎÇØ Ãâ½Ã ÀÏÁ¤ÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
  • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· : °í±Þ ·¹ÀÌÀú ½Ã½ºÅÛÀ» »ç¿ëÇÏ·Á¸é Àü¹® ±³À°ÀÌ ÇÊ¿äÇϸç Áö¿ª ¹× Àú°³¹ß Áö¿ª¿¡¼­´Â ¿©ÀüÈ÷ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº° - ÆèÅäÃÊ ·¹ÀÌÀú°¡ ½ÃÀåÀ» µ¶Á¡

ÆèÅäÃÊ ·¹ÀÌÀú´Â Á¤È®¼º, ÃÖ¼Ò Ä§½À¼º, ±¼Àý ±³Á¤ ¼ö¼ú ¹× ¹é³»Àå ¼ö¼úÀÇ È¿°ú·Î 2024³â Á¦Ç° Ä«Å×°í¸®¸¦ ¼±µµÇß½À´Ï´Ù. ¶ó½Ä, SMILE ¹× °¢¸· Àý°³¿¡¼­ÀÇ »ç¿ëÀº ½Ã·Â ±³Á¤¿¡ ´ëÇÑ È¯ÀÚÀÇ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úº° - ±¤ÀÀ°í¼úÀÌ ³Î¸® ä¿ëµÊ

±¤ÀÀ°í¼úÀº ´ç´¢º´ ¸Á¸·ÁõÀ̳ª ¸Á¸· Á¤¸Æ Æó»öÁõÀÇ Ä¡·á¿¡ ´ëÇÑ ÀÌ¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ 2024³â¿¡µµ È£Á¶¸¦ À¯ÁöÇß½À´Ï´Ù. ÀÌ ±â¼úÀº ½Ã·ÂÀ» À§ÇùÇÏ´Â Áúº´À» Àå±âÀûÀ¸·Î ¾ÈÁ¤½Ãų ¼ö Àֱ⠶§¹®¿¡ ¸Á¸· Àü¹®ÀÇµé »çÀÌ¿¡¼­ ¼±È£µË´Ï´Ù.

¿ëµµº° - ±¼ÀýÀÌ»ó ±³Á¤¿¡ ÁÖ¸ñ

2024³â ½ÃÀåÀº ±¼ÀýÀÌ»ó ±³Á¤ÀÌ Áö¹èÀûÀ̾ú½À´Ï´Ù. ¾È°æ ¹× ÄÜÅÃÆ®·»Á ´ëüÇÏ´Â ¿µ±¸ÀûÀÎ ½Ã·Â ±³Á¤ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ƯÈ÷ µµ½Ã Áö¿ªÀÇ ·¹ÀÌÀú Áö¿ø ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº° - º´¿øÀÌ ÃÖ´ë Á¡À¯À² ȹµæ

2024³â º´¿øÀº ÃÖÁ¾ ¿ëµµ ºÎ¹®À» µ¶Á¡Çß½À´Ï´Ù. º´¿ø ½Ã¼³Àº ÅëÇÕ ¾È°ú Ä¡·á ´ÜÀ§, À¯´ÉÇÑ ¿Ü°úÀÇ»ç, ÷´Ü ·¹ÀÌÀú Àåºñ¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿øÀº Áø·á º¸»ó»óÀÇ ÀÌÁ¡À» °¡Áö°í ÀÖÀ¸¸ç ¼±ÅÃÀû ¾È°ú ¼ö¼ú°ú ÀÀ±Þ ¾È°ú ¼ö¼ú ¸ðµÎ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» °®Ãß°í ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â 2024³â ¼¼°è ¾È°ú¿ë ·¹ÀÌÀú ½ÃÀå¿¡¼­ °¡Àå Å« Áö¿ªÀÌ¿´À¸¸ç, ÀÌ´Â °í±Þ ¾È°ú ¼ö¼úÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ³ôÀº ±Ù½ÃÀ² ¹× ¹é³»Àå·ü, ±×¸®°í À¯¸íÇÑ ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇÑ °ÍÀ̾ú½À´Ï´Ù. ¹Ì±¹Àº ±â¼ú µµÀÔ, »óȯ Á¦µµ, Á¤±³ÇÑ ·¹ÀÌÀú ±â¹Ý Ä¡·á¸¦ °®Ãá ¿Ü·¡ ¼ö¼ú ½Ã¼³ µîÀÇ Ãø¸é¿¡¼­ ÃÖ÷´ÜÀ» À¯ÁöÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷Àº °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ »õ·Î¿î R&D, Àü·«Àû Á¦ÈÞ, »õ·Î¿î Ãâ½Ã¸¦ ¸ð»öÇÏ°í ½ÇÇàÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, AlconÀº ÃÖ±Ù ¹é³»Àå°ú °¢¸· ¼ö¼úÀ» À§ÇÑ Â÷¼¼´ë ÆèÅäÃÊ ·¹ÀÌÀú·Î Æ÷Æ®Æú¸®¿À¸¦ ±¸ÃàÇß½À´Ï´Ù. ZEISS¿Í Johnson & JohnsonÀº ¼ö¼ú Á¤¹Ðµµ¸¦ Çâ»ó½ÃŰ´Â ÀΰøÁö´É À¯µµ ·¹ÀÌÀú Ç÷§Æû¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¹Ý´ë·Î Lumenis¿Í Glaukos´Â ¾È°ú Ŭ¸®´Ð ¹× º´¿ø°ú Á¦ÈÞÇÏ¿© ÆÇ¸Å ä³ÎÀ» ´õ Àß Áö¿øÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù. BAUSCH LOMB°ú NIDEKÀº ÇöÁö »ý»êÀ» ¸ð»öÇÏ°í ¾È°ú ÀÇ»çÀÇ ÈÆ·ÃÀ» ½Ç½ÃÇÔÀ¸·Î½á ½ÅÈï ½ÃÀå¿¡ ÃÊÁ¡À» ¸ÂÃá ¼ºÀå Àü·«À» ½Ç½ÃÇß½À´Ï´Ù. À̸¦ ÅëÇØ ¼¼°èÀûÀÎ µµ´Þ ¹üÀ§°¡ ´õ¿í ³Ð¾îÁú »Ó¸¸ ¾Æ´Ï¶ó ±â¼úÀÌ Áøº¸µÇ°í ȯÀÚÀÇ Ä¡·á ¼ºÀûÀÌ Çâ»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¾÷°èÀÇ »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¾ÈÁúȯÀÇ À¯º´·ü Áõ°¡
      • Àúħ½À ¾È°ú ¼ö¼ú ¼ö¿ä Áõ°¡
      • ·¹ÀÌÀú ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸
      • ¼±Áø±¹ ½ÃÀå¿¡¼­ º¸Çè»óȯ Á¤¼¼ °³¼±
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© ¹× °úÁ¦
      • ¾È°ú¿ë ·¹ÀÌÀú ½Ã½ºÅÛÀÇ °íºñ¿ë
      • ¼ö¼ú ÈÄ ÇÕº´Áõ, ºÎÀÛ¿ëÀÇ À§Çè
    • ½ÃÀå ±âȸ
      • ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÈï ½ÃÀå
      • ¾Æ¿ô¸®Ä¡ ÇÁ·Î±×·¥¿ë ÈÞ´ë °¡´ÉÇϰí ÄÄÆÑÆ®ÇÑ ·¹ÀÌÀú Ç÷§Æû
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ȯ±Þ ½Ã³ª¸®¿À
  • ±â¼úÀÇ »óȲ
    • ÇöÀçÀÇ ±â¼ú µ¿Çâ
    • ½ÅÈï±â¼ú
  • °¡°Ý ºÐ¼® : Á¦Ç° À¯Çüº°, 2024³â
  • °¸ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • ¹Ì·¡ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼Ò°³
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
    • ¼¼°è
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • ÁÖ¿ä ¹ßÀü
    • ÀμöÇÕº´
    • ÆÄÆ®³Ê½Ê ¹× Çù¾÷
    • ½ÅÁ¦Ç° À¯ÇüÀÇ ¹ß¸Å
    • È®Àå °èȹ

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ÆèÅäÃÊ ·¹ÀÌÀú
  • ´ÙÀÌ¿Àµå ·¹ÀÌÀú
  • ¿¢½Ã¸Ó ·¹ÀÌÀú
  • Nd:YAG ·¹ÀÌÀú
  • ±âŸ Á¦Ç° À¯Çü

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ±â¼úº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ±¤ÀÀ°í¼ú
  • ±¤ÆÄ±«¼ú
  • ¾îºí·¹À̼Ç
  • ±âŸ ±â¼ú

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ±¼Àý ÀÌ»ó ±³Á¤
  • ¹é³»Àå ¼ö¼ú
  • ´ç´¢º´ ¸Á¸·Áõ
  • ³ì³»Àå
  • ±âŸ ¿ëµµ

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ ¿ëµµ

Á¦9Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ¼¼°è ±â¾÷
    • Alcon
    • BAUSCH LOMB
    • Johnson & Johnson
    • LUMENIS
    • NIDEK
    • ZEISS
  • Áö¿ª ±â¾÷
    • LIGHTMED
    • LUMIBIRD MEDICAL
    • Meridian Medical
    • TOPCON Healthcare
  • ½ÅÈï ±â¾÷
    • ARC LASER
    • Glaukos
    • IRIDEX
    • Ziemer Ophthalmology
JHS

The global ophthalmic lasers market was valued at USD 1.8 billion in 2024 and is projected to grow from USD 1.9 billion in 2025 to USD 3.1 billion by 2034, at a CAGR of 5.9%, according to the latest report published by Global Market Insights, Inc. The market is experiencing significant growth with the growing incidence of vision disorders, the aging population, and technological advancements in laser systems for eye procedures.

Ophthalmic Lasers Market - IMG1

Ophthalmic lasers have emerged as vital for the treatment of diseases like glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive errors. Ophthalmic lasers are minimally invasive instruments that deliver precise and effective surgical treatments, and therefore are expected to show increased uptake over the next few years.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1.8 Billion
Forecast Value$3.1 Billion
CAGR5.9%

Key Drivers:

1. Rising incidences of eye diseases: Increasing numbers of cataracts, diabetic retinopathy, and glaucoma are favoring the demand for laser-based treatments.

2. Rise in refractive surgeries: Increased interest in LASIK and SMILE surgeries among young generations is driving the usage of femtosecond and excimer lasers.

3. Improved precision and safety of lasers: New ophthalmic lasers provide enhanced control, less thermal damage, and better post-op results, thus gaining traction among ophthalmologists.

4. Aging population: Age-related eye conditions are on the rise worldwide, particularly in high-income and middle-income nations.

Key Players:

  • Alcon, Johnson & Johnson, ZEISS, LUMENIS, and NIDEK are some of the key players, together commanding 59.3% of the overall market.
  • Alcon captured an 18.2% share of the ophthalmic lasers market in 2024.

Key Challenges:

  • High cost of equipment: Ophthalmic lasers are expensive, which hinders their penetration in low-income healthcare facilities.
  • Strict regulatory approvals: Device approval delays in various markets may limit launch schedules.
  • Scarcity of skilled professionals: Specialized training is needed for the use of sophisticated laser systems, which is still an issue in rural and underdeveloped regions.

By Product Type - Femtosecond Lasers Dominate the Market

Femtosecond lasers led the product category in 2024 with their precision, minimal invasiveness, and efficacy in refractive and cataract surgeries. Their use in LASIK, SMILE, and corneal incisions is increasing rapidly due to the increasing patient interest in vision correction continues to rise worldwide.

By Technology - Photocoagulation witnessed widespread Adoption

The photocoagulation segment sustained a strong position in 2024, particularly because of the increasing usage in the treatment of diabetic retinopathy and retinal vein occlusions. The technology is preferred among retinal specialists as it offers long-term stabilization of vision-threatening disease.

By Application - Refractive Error Correction Remains in Focus

Refractive error correction dominated the market in 2024. Growing demand for permanent vision correction solutions to glasses and contact lenses is propelling the demand for laser-assisted procedures, especially in urban areas.

By End Use - Hospitals Captured the Biggest Share

Hospitals dominated the end-use segment in 2024. Hospital facilities have integrated eye care units, qualified surgeons, and high-tech laser equipment. They also offer reimbursement benefits and have the capacity to treat both elective and emergency ophthalmic surgeries.

North America was the biggest player in the global ophthalmic lasers market in 2024, driven by extensive use of advanced ophthalmic surgeries, high myopia and cataract rates, and the presence of prominent players. The U.S. remains at the forefront in terms of technology adoption, reimbursement schemes, and outpatient surgical facilities with sophisticated laser-based treatments.

Top players are exploring and executing new research and development, strategic partnerships, and new launches for competitive advantage. As an example, Alcon has recently built its portfolio with next-generation femtosecond lasers for cataract and corneal surgery. ZEISS and Johnson & Johnson are focused on artificial intelligence-guided laser platforms to improve surgical precision. Conversely, Lumenis and Glaukos aim to partner with eye clinics and hospitals to better support their distribution channels. BAUSCH + LOMB and NIDEK implement growth strategies focused on emerging markets by exploring local production and also training ophthalmologists. This will further global reach but also advance technology and improve patient care outcomes.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 Technology trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of eye disorders
      • 3.2.1.2 Growing demand for minimally invasive ophthalmic surgeries
      • 3.2.1.3 Technological advancements in laser systems
      • 3.2.1.4 Improved reimbursement landscape in developed markets
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of ophthalmic laser systems
      • 3.2.2.2 Risk of postoperative complications and side effects
    • 3.2.3 Market opportunities
      • 3.2.3.1 Emerging markets in Asia-Pacific, Latin America, and MEA
      • 3.2.3.2 Portable and compact laser platforms for outreach programs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 MEA
  • 3.5 Reimbursement scenario
  • 3.6 Technology landscape
    • 3.6.1 Current technological trends
    • 3.6.2 Emerging technologies
  • 3.7 Pricing analysis, By product type, 2024
  • 3.8 Gap analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis
  • 3.11 Future market trends
  • 3.12 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LATAM and MEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Femtosecond lasers
  • 5.3 Diode lasers
  • 5.4 Excimer lasers
  • 5.5 Nd:YAG lasers
  • 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Photocoagulation
  • 6.3 Photodisruption
  • 6.4 Ablation
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Refractive error correction
  • 7.3 Cataract surgery
  • 7.4 Diabetic retinopathy
  • 7.5 Glaucoma
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ophthalmic clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Global Players
    • 10.1.1 Alcon
    • 10.1.2 BAUSCH + LOMB
    • 10.1.3 Johnson & Johnson
    • 10.1.4 LUMENIS
    • 10.1.5 NIDEK
    • 10.1.6 ZEISS
  • 10.2 Regional Players
    • 10.2.1 LIGHTMED
    • 10.2.2 LUMIBIRD MEDICAL
    • 10.2.3 Meridian Medical
    • 10.2.4 TOPCON Healthcare
  • 10.3 Emerging Players
    • 10.3.1 A.R.C. LASER
    • 10.3.2 Glaukos
    • 10.3.3 IRIDEX
    • 10.3.4 Ziemer Ophthalmology
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦